CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Chenodeoxycholic Acid

鹅去氧胆酸 杂质对照品Chenodeoxycholic Acid Impurities

EP29 个杂质条目29 impurity entries

本页汇总 鹅去氧胆酸 的 29 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 29 impurity reference standards of Chenodeoxycholic Acid with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 鹅去氧胆酸(Chenodeoxycholic Acid)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesChallenges in the identification and quantification of an unknown impurity in chenodeoxycholic acid drug substance
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2025 · Bouwhuis N et al.  ·  PMID 39643128  ·  DOI
  2. 杂质研究Impurity studiesLimited sample stability of chenodeoxycholic acid in pharmaceutical quality control
    European journal of hospital pharmacy : science and practice · 2026 · Bouwhuis N et al.  ·  PMID 41871933  ·  DOI
  3. 分析方法Analytical MethodsRadioimmunoassay of chenodeoxycholic acid-3-sulfate in urine
    Journal of lipid research · 1988 · Matsuoka M, Okumura M  ·  PMID 3392468

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisPractical synthesis of chenodeoxycholic acid from phocaecholic acid
    Steroids · 2024 · He Z et al.  ·  PMID 38997080  ·  DOI
  • 合成方法SynthesisEffects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects
    Hepatology (Baltimore, Md.) · 2001 · Einarsson C et al.  ·  PMID 11343248  ·  DOI

鹅去氧胆酸 —— 原料药与杂质对照品Chenodeoxycholic Acid — drug substance & impurities

共 30 个条目(含原料药本体)30 items incl. the drug substance
Chenodeoxycholic Acid structure
EP原料药 APIAPI
鹅去氧胆酸Chenodeoxycholic Acid
Chenodeoxycholic Acid
CAS No.474-25-9
Chemical FormulaC24H40O4
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 1(Chenodeoxycholic Acid EP Impurity A) structure
EPA
鹅去氧胆酸杂质1(鹅去氧胆酸EP杂质A)Chenodeoxycholic Acid Impurity 1(Chenodeoxycholic Acid EP Impurity A)
Chenodeoxycholic Acid Impurity 1(Chenodeoxycholic Acid EP Impurity A)
CAS No.128-13-2
Chemical FormulaC24H40O4
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 2 Sodium Salt (Chenodeoxycholic Acid EP Impurity B Sodium Salt) structure
EPB
鹅去氧胆酸杂质2 钠盐 (鹅去氧胆酸EP杂质B 钠盐)Chenodeoxycholic Acid Impurity 2 Sodium Salt (Chenodeoxycholic Acid EP Impurity B Sodium Salt)
Chenodeoxycholic Acid Impurity 2 Sodium Salt (Chenodeoxycholic Acid EP Impurity B Sodium Salt)
CAS No.361-09-1
Chemical FormulaC24H39O5-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 2 (Chenodeoxycholic Acid EP Impurity B) structure
EPB
鹅去氧胆酸杂质2 (鹅去氧胆酸EP杂质B)Chenodeoxycholic Acid Impurity 2 (Chenodeoxycholic Acid EP Impurity B)
Chenodeoxycholic Acid Impurity 2 (Chenodeoxycholic Acid EP Impurity B)
CAS No.81-25-4
Chemical FormulaC24H40O5
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 5 (Chenodeoxycholic Acid EP Impurity E) structure
EPE
鹅去氧胆酸杂质5 (鹅去氧胆酸EP杂质E)Chenodeoxycholic Acid Impurity 5 (Chenodeoxycholic Acid EP Impurity E)
Chenodeoxycholic Acid Impurity 5 (Chenodeoxycholic Acid EP Impurity E)
CAS No.83-44-3
Chemical FormulaC24H40O4
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 6(Chenodeoxycholic Acid EP Impurity F) structure
EPF
鹅去氧胆酸杂质6(鹅去氧胆酸EP杂质F)Chenodeoxycholic Acid Impurity 6(Chenodeoxycholic Acid EP Impurity F)
Chenodeoxycholic Acid Impurity 6(Chenodeoxycholic Acid EP Impurity F)
CAS No.4651-67-6
Chemical FormulaC24H38O4
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 7 (Chenodeoxycholic Acid EP Impurity G) structure
EPG
鹅去氧胆酸杂质7 (鹅去氧胆酸EP杂质G)Chenodeoxycholic Acid Impurity 7 (Chenodeoxycholic Acid EP Impurity G)
Chenodeoxycholic Acid Impurity 7 (Chenodeoxycholic Acid EP Impurity G)
CAS No.10538-55-3
Chemical FormulaC25H42O4
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 2-d4 (Chenodeoxycholic Acid EP Impurity B-d4) structure
EPB-D4
鹅去氧胆酸杂质2-d4 (鹅去氧胆酸EP杂质B-d4)Chenodeoxycholic Acid Impurity 2-d4 (Chenodeoxycholic Acid EP Impurity B-d4)
Chenodeoxycholic Acid Impurity 2-d4 (Chenodeoxycholic Acid EP Impurity B-d4)
CAS No.116380-66-6
Chemical FormulaC24H36D4O5
Purity>95%询价On request
Chenodeoxycholic Acid Impurity 3 structure
3
鹅去氧胆酸杂质3Chenodeoxycholic Acid Impurity 3
Chenodeoxycholic Acid Impurity 3
CAS No.434-13-9
Chemical FormulaC24H40O3
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 4 structure
4
鹅去氧胆酸杂质4Chenodeoxycholic Acid Impurity 4
Chenodeoxycholic Acid Impurity 4
CAS No.2955-27-3
Chemical FormulaC24H40O5
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 9 (Glycochenodeoxycholic Acid Sodium Salt) structure
9
鹅去氧胆酸杂质9 (甘氨鹅去氧胆酸钠盐)Chenodeoxycholic Acid Impurity 9 (Glycochenodeoxycholic Acid Sodium Salt)
Chenodeoxycholic Acid Impurity 9 (Glycochenodeoxycholic Acid Sodium Salt)
CAS No.16564-43-5
Chemical FormulaC26H42NO5-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 9 Monomer (Glycochenodeoxycholic Acid) structure
9
鹅去氧胆酸杂质9 单体 (甘氨鹅去氧胆酸)Chenodeoxycholic Acid Impurity 9 Monomer (Glycochenodeoxycholic Acid)
Chenodeoxycholic Acid Impurity 9 Monomer (Glycochenodeoxycholic Acid)
CAS No.640-79-9
Chemical FormulaC26H43NO5
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 10 structure
10
鹅去氧胆酸杂质10Chenodeoxycholic Acid Impurity 10
Chenodeoxycholic Acid Impurity 10
CAS No.2458-08-4
Chemical FormulaC24H38O5
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 11 structure
11
鹅去氧胆酸杂质11Chenodeoxycholic Acid Impurity 11
Chenodeoxycholic Acid Impurity 11
CAS No.2958-05-6
Chemical FormulaC24H36O4
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 12 structure
12
鹅去氧胆酸杂质12Chenodeoxycholic Acid Impurity 12
Chenodeoxycholic Acid Impurity 12
CAS No.81938-67-2
Chemical FormulaC24H40O5
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 13 structure
13
鹅去氧胆酸杂质13Chenodeoxycholic Acid Impurity 13
Chenodeoxycholic Acid Impurity 13
CAS No.80434-32-8
Chemical FormulaC24H40O5
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 14 structure
14
鹅去氧胆酸杂质14Chenodeoxycholic Acid Impurity 14
Chenodeoxycholic Acid Impurity 14
CAS No.15173-22-5
Chemical FormulaC24H40O3
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 15 structure
15
鹅去氧胆酸杂质15Chenodeoxycholic Acid Impurity 15
Chenodeoxycholic Acid Impurity 15
CAS No.96840-44-7
Chemical FormulaC24H42N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 16 (Lithocholylglycine) structure
16
鹅去氧胆酸杂质16 (甘氨石胆酸)Chenodeoxycholic Acid Impurity 16 (Lithocholylglycine)
Chenodeoxycholic Acid Impurity 16 (Lithocholylglycine)
CAS No.474-74-8
Chemical FormulaC26H43NO4
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 17 (Taurochenodeoxycholic Acid) structure
17
鹅去氧胆酸杂质17 (牛磺鹅去氧胆酸)Chenodeoxycholic Acid Impurity 17 (Taurochenodeoxycholic Acid)
Chenodeoxycholic Acid Impurity 17 (Taurochenodeoxycholic Acid)
CAS No.516-35-8
Chemical FormulaC26H45NO6S
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 17  Sodium Salt (Taurochenodeoxycholic Acid Sodium Salt) structure
17
鹅去氧胆酸杂质17 钠盐 (牛磺鹅去氧胆酸钠)Chenodeoxycholic Acid Impurity 17 Sodium Salt (Taurochenodeoxycholic Acid Sodium Salt)
Chenodeoxycholic Acid Impurity 17 Sodium Salt (Taurochenodeoxycholic Acid Sodium Salt)
CAS No.6009-98-9
Chemical FormulaC26H44NO6S-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 18(Allochenodeoxycholic Acid) structure
18
鹅去氧胆酸杂质18(别鹅去氧胆酸)Chenodeoxycholic Acid Impurity 18(Allochenodeoxycholic Acid)
Chenodeoxycholic Acid Impurity 18(Allochenodeoxycholic Acid)
CAS No.15357-34-3
Chemical FormulaC24H40O4
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 19 structure
19
鹅去氧胆酸杂质19Chenodeoxycholic Acid Impurity 19
Chenodeoxycholic Acid Impurity 19
CAS No.5255-17-4
Chemical FormulaC24H38O3
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 20 structure
20
鹅去氧胆酸杂质20Chenodeoxycholic Acid Impurity 20
Chenodeoxycholic Acid Impurity 20
CAS No.83896-19-9
Chemical FormulaC24H40N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 21 structure
21
鹅去氧胆酸杂质21Chenodeoxycholic Acid Impurity 21
Chenodeoxycholic Acid Impurity 21
CAS No.1024498-33-6
Chemical FormulaC48H76N2O8
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 22 structure
22
鹅去氧胆酸杂质22Chenodeoxycholic Acid Impurity 22
Chenodeoxycholic Acid Impurity 22
CAS No.1422447-13-9
Chemical FormulaC30H47NO8
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 24 structure
24
鹅去氧胆酸杂质24Chenodeoxycholic Acid Impurity 24
Chenodeoxycholic Acid Impurity 24
CAS No.10601-78-2
Chemical FormulaC24H40O3
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 25 structure
25
鹅去氧胆酸杂质25Chenodeoxycholic Acid Impurity 25
Chenodeoxycholic Acid Impurity 25
CAS No.51446-79-8
Chemical FormulaC24H40O4
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 26 structure
26
鹅去氧胆酸杂质26Chenodeoxycholic Acid Impurity 26
Chenodeoxycholic Acid Impurity 26
CAS No.1144012-08-7
Chemical FormulaC24H38O4
Purity>95%询价On request
10mg25mg50mg100mg
Chenodeoxycholic Acid Impurity 27 structure
27
鹅去氧胆酸杂质27Chenodeoxycholic Acid Impurity 27
Chenodeoxycholic Acid Impurity 27
CAS No.171524-54-2
Chemical FormulaC24H40O5
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

鹅去氧胆酸 —— 研究文献与合成路线Chenodeoxycholic Acid — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 鹅去氧胆酸 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Chenodeoxycholic Acid. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. The degradation of chenodeoxycholic acid by Pseudomonas Spp. N.C.I.B. 10590
    Tenneson ME, Baty JD, Bilton RF, et al. · Journal of steroid biochemistry · 1979 · 被引 15cited 15
  2. Challenges in the identification and quantification of an unknown impurity in chenodeoxycholic acid drug substance
    Bouwhuis N, Polak Y, Schimmel AM, et al. · European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2025 · 被引 2cited 2
  3. [The significance of the bacterial steroid degradation for the etiology of large bowel cancer. V. Transformation of chenodeoxycholic acid by saccharolytic bacteroides-species (author's transl)]
    Edenharder R, Stubenrauch S, Slemrova J · Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe B: Hygiene, praventive Medizin · 1976 · 被引 2cited 2
  4. Simultaneous Determination of Ursodeoxycholic Acid and Chenodeoxycholic Acid in Pharmaceutical Dosage Form by HPLC-UV Detection
    Khairy MA, Mansour FR · Journal of AOAC International · 2017 · 被引 5cited 5

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR PREPARING DOUBLE MAGENIUM SALT OF URSODEOXYCHOLIC ACID AND CHENODEOXYCHOLIC ACID
    HONG YU HWA, LEE YONG ARM, SHIN HYE JUNG, LEE JIN A · 公开号 KR20120032654KR20120032654 · 2012
  2. PURIFICATION PROCESS FOR CHENODEOXYCHOLIC ACID
    KIM TAE YI, KIM YOUNG SOO, LIM YOUNG MOOK, KIM WOL YOUNG, et al. · 公开号 EP1966228EP1966228 · 2008
  3. Purification process for chenodeoxycholic acid
    — · 公开号 CN101365711CN101365711 · 2009
  4. PURIFICATION PROCESS FOR CHENODEOXYCHOLIC ACID
    KIM Tae Yi, KIM Young Soo, LIM Young Mook, KIM Wol Young, et al. · 公开号 WO2007069814WO2007069814 · 2007
  5. Synthesis method of chenodeoxycholic acid
    MENG YANQIU ZHANG · 公开号 CN1869043CN1869043 · 2006

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

鹅去氧胆酸 杂质谱研究要点Chenodeoxycholic Acid — impurity profiling notes

下面这些是拿到 鹅去氧胆酸 的 30 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 30 impurity entries for Chenodeoxycholic Acid, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances